Barrett's Esophagus is a change in the lining of your esophagus caused by long-term exposure to stomach acid. Over time, the normal squamous cells are replaced by columnar cells that more closely resemble those in the intestine. This cellular transformation raises the risk of developing esophageal cancer, making early detection and monitoring vital.
Early Barrett's Esophagus may not cause noticeable symptoms. When they do occur, they often mirror chronic acid reflux:
Barrett's Esophagus most commonly arises from prolonged acid reflux damaging the esophageal lining. Key risk factors include:
At GastroDoxs in Houston, our expert team specializes in Barrett's Esophagus care-from early detection with advanced endoscopic techniques to personalized treatment plans and ongoing monitoring. We're committed to guiding you every step of the way, offering compassionate support and clear communication. Book your appointment today to partner with Houston’s trusted gastroenterology specialists and take control of your esophageal health.
We've successfully treated more than 4.3K patients, helping individuals improve their digestive health and overall well-being through expert, personalized care.
With over 20 years of experience, GastroDoxs has been a trusted provider of gastroenterology care, focusing on delivering the best outcomes for patients
The ICD-10 code for Barrett's Esophagus is K22.7, which is used in medical records and billing to identify this specific condition.
Many patients have no early symptoms. When they do occur, they often mimic chronic acid reflux and may include heartburn, chest burning, pain when swallowing, regurgitation of sour fluid, a persistent cough, hoarseness, or unexplained weight loss.
Long-term exposure to stomach acid from GERD (gastroesophageal reflux disease) is the primary cause. Other risk factors include hiatal hernia, smoking, alcohol use, obesity around the waist, and a family history of Barrett's or esophageal cancer.
Yes, Barrett's Esophagus raises the risk of developing esophageal adenocarcinoma. Regular monitoring and early treatment of precancerous changes help keep the risk low.
"Barrett's without dysplasia" indicates that the normal esophageal cells have changed but no precancerous (dysplastic) cells are present. It still requires periodic surveillance to catch any early cell changes.
Treatment aims to reduce acid exposure, remove or destroy abnormal cells, and prevent progression to cancer. Options include proton pump inhibitors (PPIs), H2 blockers, endoscopic ablation or mucosal resection, and in some cases, surgical fundoplication.
A low-acid, low-fat diet is recommended. Focus on lean proteins, non-citrus fruits, vegetables, whole grains, and avoid spicy foods, caffeine, alcohol, and other triggers that worsen reflux.
Yes. Proton pump inhibitors (PPIs) and H2 receptor blockers reduce stomach acid, promote healing of the esophageal lining, and help control reflux symptoms.
Yes. A gastroenterologist with expertise in Barrett's Esophagus provides accurate diagnosis, personalized treatment, and ongoing surveillance to minimize cancer risk.
For Barrett's Esophagus without dysplasia, endoscopy is typically recommended every 3-5 years. If low- or high-grade dysplasia is found, more frequent surveillance or therapeutic endoscopic procedures may be advised.